Alshaya, O.A.; Korayem, G.B.; Al Yami, M.S.; Qudayr, A.H.; Althewaibi, S.; Fetyani, L.; Alshehri, S.; Alnashmi, F.; Albasseet, M.; Alshehri, L.;
et al. Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study. J. Clin. Med. 2023, 12, 199.
https://doi.org/10.3390/jcm12010199
AMA Style
Alshaya OA, Korayem GB, Al Yami MS, Qudayr AH, Althewaibi S, Fetyani L, Alshehri S, Alnashmi F, Albasseet M, Alshehri L,
et al. Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study. Journal of Clinical Medicine. 2023; 12(1):199.
https://doi.org/10.3390/jcm12010199
Chicago/Turabian Style
Alshaya, Omar A., Ghazwa B. Korayem, Majed S. Al Yami, Asma H. Qudayr, Sara Althewaibi, Lolwa Fetyani, Shaden Alshehri, Fai Alnashmi, Maram Albasseet, Lina Alshehri,
and et al. 2023. "Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study" Journal of Clinical Medicine 12, no. 1: 199.
https://doi.org/10.3390/jcm12010199
APA Style
Alshaya, O. A., Korayem, G. B., Al Yami, M. S., Qudayr, A. H., Althewaibi, S., Fetyani, L., Alshehri, S., Alnashmi, F., Albasseet, M., Alshehri, L., Alhushan, L. M., & Almohammed, O. A.
(2023). Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study. Journal of Clinical Medicine, 12(1), 199.
https://doi.org/10.3390/jcm12010199
